Home9IP1 • FRA
add
Rocket Pharmaceuticals Inc
Previous close
€2.35
Day range
€2.28 - €2.28
Year range
€1.85 - €23.53
Market cap
310.29M USD
Avg Volume
479.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 64.39M | -4.43% |
Net income | -61.33M | 1.16% |
Net profit margin | — | — |
Earnings per share | -0.56 | 15.15% |
EBITDA | -61.40M | 5.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 318.16M | -3.68% |
Total assets | 471.07M | -5.68% |
Total liabilities | 58.93M | 1.71% |
Total equity | 412.14M | — |
Shares outstanding | 107.74M | — |
Price to book | 0.61 | — |
Return on assets | -32.23% | — |
Return on capital | -34.76% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -61.33M | 1.16% |
Cash from operations | -55.79M | 1.87% |
Cash from investing | -58.04M | -265.65% |
Cash from financing | — | — |
Net change in cash | -113.82M | -451.53% |
Free cash flow | -33.46M | 41.75% |
About
Founded
1999
Headquarters
Website
Employees
299
